未登录
分享
收藏
分享
收藏
分享
收藏iGlarLixi provides improved early glycaemic control after 12 weeks of treatment compared with basal insulin in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan-O-AP and LixiLan-L-CN studies与基础胰岛素相比,iGlarLixi在亚洲2型糖尿病患者中治疗12周后可改善早期血糖控制: LixiLan-O-AP和LixiLan-L-CN研究的事后分析
Song, Lulu; Yuan, Xiaoyong; Huang, Shan; Zhang, Yawei; Lauand, Felipe; Wang, Zhini; Zhang, Jie; Du, Qin; Kang, Lei; Yang, Wenying; Guo, Xiaohui
分享
收藏
分享
收藏
分享
收藏